NK Cell-Mediated Antibody-Dependent Cellular Cytotoxicity in Cancer Immunotherapy von Wang, Wei, Erbe, Amy K, Hank, Jacquelyn A, Morris, Zachary S, Sondel, Paul M

Volltext

Rhamnose Glycoconjugates for the Recruitment of Endogenous Anti-Carbohydrate Antibodies to Tumor Cells von Sheridan, Rachael T. C., Hudon, Jonathan, Hank, Jacquelyn A., Sondel, Paul M., Kiessling, Laura L.

Volltext

Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study von SHUSTERMAN, Suzanne, LONDON, Wendy B, GAN, Jacek, EICKHOFF, Jens, DESANTES, Kenneth B, COHN, Susan L, HECHT, Toby, GADBAW, Brian, REISFELD, Ralph A, MARIS, John M, SONDEL, Paul M, GILLIES, Stephen D, HANK, Jacquelyn A, VOSS, Stephan D, SEEGER, Robert C, REYNOLDS, C. Patrick, KIMBALL, Jennifer, ALBERTINI, Mark R, WAGNER, Barrett

Volltext

Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition von Voeller, Julie, Erbe, Amy K., Slowinski, Jacob, Rasmussen, Kayla, Carlson, Peter M., Hoefges, Anna, VandenHeuvel, Sabrina, Stuckwisch, Ashley, Wang, Xing, Gillies, Stephen D., Patel, Ravi B., Farrel, Alvin, Rokita, Jo Lynne, Maris, John, Hank, Jacquelyn A., Morris, Zachary S., Rakhmilevich, Alexander L., Sondel, Paul M.

Volltext

Radiation Augments the Local Anti-Tumor Effect of In Situ Vaccine With CpG-Oligodeoxynucleotides and Anti-OX40 in Immunologically Cold Tumor Models von Pieper, Alexander A, Zangl, Luke M, Speigelman, Dan V, Feils, Arika S, Hoefges, Anna, Jagodinsky, Justin C, Felder, Mildred A, Tsarovsky, Noah W, Arthur, Ian S, Brown, Ryan J, Birstler, Jen, Le, Trang, Carlson, Peter M, Bates, Amber M, Hank, Jacquelyn A, Rakhmilevich, Alexander L, Erbe, Amy K, Sondel, Paul M, Patel, Ravi B, Morris, Zachary S

Volltext

Combination of radiation therapy, bempegaldesleukin, and checkpoint blockade eradicates advanced solid tumors and metastases in mice von Pieper, Alexander A, Rakhmilevich, Alexander L, Spiegelman, Daniel V, Patel, Ravi B, Birstler, Jen, Jin, Won Jong, Carlson, Peter M, Charych, Deborah H, Hank, Jacquelyn A, Erbe, Amy K, Overwijk, Willem W, Morris, Zachary S, Sondel, Paul M

Volltext

Human NK cells maintain licensing status and are subject to killer immunoglobulin-like receptor (KIR) and KIR-ligand inhibition following ex vivo expansion von Wang, Wei, Erbe, Amy K., Alderson, Kory A., Phillips, Emily, Gallenberger, Mikayla, Gan, Jacek, Campana, Dario, Hank, Jacquelyn A., Sondel, Paul M.

Volltext

Phase I Study of ch14.18 With Granulocyte-Macrophage Colony-Stimulating Factor and Interleukin-2 in Children With Neuroblastoma After Autologous Bone Marrow Transplantation or Stem... von Gilman, Andrew L, Ozkaynak, M Fevzi, Matthay, Katherine K, Krailo, Mark, Yu, Alice L, Gan, Jacek, Sternberg, Adam, Hank, Jacquelyn A, Seeger, Robert, Reaman, Gregory H, Sondel, Paul M

Volltext

A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu14.18K322A in recurrent/refractory solid tumors von Bishop, Michael W, Hutson, Paul R, Hank, Jacquelyn A, Sondel, Paul M, Furman, Wayne L, Meagher, Michael M, Navid, Fariba, Santana, Victor M

Volltext

Human and murine IL2 receptors differentially respond to the human-IL2 component of immunocytokines von Perez Horta, Zulmarie, Saseedhar, Swetha, Rakhmilevich, Alexander L., Carmichael, Lakeesha, Hank, Jacquelyn A., Boyden, Margaret, Gillies, Stephen D., Sondel, Paul M.

Volltext

Intratumoral injection reduces toxicity and antibody-mediated neutralization of immunocytokine in a mouse melanoma model von Baniel, Claire C, Sumiec, Elizabeth G, Hank, Jacquelyn A, Bates, Amber M, Erbe, Amy K, Pieper, Alexander A, Hoefges, Anna G, Patel, Ravi B, Rakhmilevich, Alexander L, Morris, Zachary S, Sondel, Paul M

Volltext

A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children's Oncology Gro... von OSENGA, Kaci L, HANK, Jacquelyn A, KRAILO, Mark, ADAMSON, Peter C, REISFELD, Ralph A, GILLIES, Stephen D, SONDEL, Paul M, ALBERTINI, Mark R, GAN, Jacek, STERNBERG, Adam G, EICKHOFF, Jens, SEEGER, Robert C, MATTHAY, Katherine K, REYNOLDS, C. Patrick, TWIST, Clare

Volltext

Long-Term Follow-up of a Phase III Study of ch14.18 (Dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032 von Yu, Alice L, Gilman, Andrew L, Ozkaynak, M Fevzi, Naranjo, Arlene, Diccianni, Mitchell B, Gan, Jacek, Hank, Jacquelyn A, Batova, Ayse, London, Wendy B, Tenney, Sheena C, Smith, Malcolm, Shulkin, Barry L, Parisi, Marguerite, Matthay, Katherine K, Cohn, Susan L, Maris, John M, Bagatell, Rochelle, Park, Julie R, Sondel, Paul M

Volltext

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy von Erbe, Amy K, Wang, Wei, Reville, Patrick K, Carmichael, Lakeesha, Kim, KyungMann, Mendonca, Eneida A, Song, Yiqiang, Hank, Jacquelyn A, London, Wendy B, Naranjo, Arlene, Hong, Fangxin, Hogarty, Michael D, Maris, John M, Park, Julie R, Ozkaynak, M F, Miller, Jeffrey S, Gilman, Andrew L, Kahl, Brad, Yu, Alice L, Sondel, Paul M

Volltext

Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children's Oncology Group von Mody, Rajen, Yu, Alice L, Naranjo, Arlene, Zhang, Fan F, London, Wendy B, Shulkin, Barry L, Parisi, Marguerite T, Servaes, Sabah-E-Noor, Diccianni, Mitchell B, Hank, Jacquelyn A, Felder, Mildred, Birstler, Jennifer, Sondel, Paul M, Asgharzadeh, Shahab, Glade-Bender, Julia, Katzenstein, Howard, Maris, John M, Park, Julie R, Bagatell, Rochelle

Volltext

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab von Erbe, Amy K, Wang, Wei, Carmichael, Lakeesha, Hoefges, Anna, Grzywacz, Bartosz, Reville, Patrick K, Ranheim, Erik A, Hank, Jacquelyn A, Kim, KyungMann, Seo, Songwon, Mendonca, Eneida A, Song, Yiqiang, Kenkre, Vaishalee P, Hong, Fangxin, Gascoyne, Randy D, Paietta, Elisabeth, Horning, Sandra J, Miller, Jeffrey S, Kahl, Brad, Sondel, Paul M

Volltext

Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A von Furman, Wayne L, McCarville, Beth, Shulkin, Barry L, Davidoff, Andrew, Krasin, Matthew, Hsu, Chia-Wei, Pan, Haitao, Wu, Jianrong, Brennan, Rachel, Bishop, Michael W, Helmig, Sara, Stewart, Elizabeth, Navid, Fariba, Triplett, Brandon, Santana, Victor, Santiago, Teresa, Hank, Jacquelyn A, Gillies, Stephen D, Yu, Alice, Sondel, Paul M, Leung, Wing H, Pappo, Alberto, Federico, Sara M

Volltext

Phase I Clinical Trial of the Immunocytokine EMD 273063 in Melanoma Patients von KING, David M, ALBERTINI, Mark R, EICKHOFF, Jens, KENDRA, Kari, REISFELD, Ralph, GILLIES, Stephen D, SONDEL, Paul, SCHALCH, Heidi, HANK, Jacquelyn A, GAN, Jacek, SURFUS, Jean, MAHVI, David, SCHILLER, Joan H, WARNER, Thomas, KIM, Kyungmann

Volltext

A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory Neuroblastoma von Federico, Sara M, McCarville, M Beth, Shulkin, Barry L, Sondel, Paul M, Hank, Jacquelyn A, Hutson, Paul, Meagher, Michael, Shafer, Aaron, Ng, Catherine Y, Leung, Wing, Janssen, William E, Wu, Jianrong, Mao, Shenghua, Brennan, Rachel C, Santana, Victor M, Pappo, Alberto S, Furman, Wayne L

Volltext

Immunogenicity of the Hu14.18-IL2 Immunocytokine Molecule in Adults With Melanoma and Children With Neuroblastoma von Hank, Jacquelyn A, Gan, Jacek, Ryu, Hyunji, Ostendorf, Amy, Stauder, Michael C, Sternberg, Adam, Albertini, Mark, Lo, Kin-Ming, Gillies, Stephen D, Eickhoff, Jens, Sondel, Paul M

Volltext